SV Life Sciences "exceeds target" in raising its fifth VC fund
This article was originally published in Scrip
Executive Summary
The venture capital firm SV Life Sciences has completed the final closing of its newest fund, SV Life Sciences Fund V, with total commitments of more than $523 million, exceeding its target of $400 million.